ARTICLE | Company News
Netherlands approves Astellas' Vesomni
May 24, 2013 12:34 AM UTC
Astellas Pharma Inc. (Tokyo:4503) said the Netherlands Medicines Evaluation Board approved an MAA for Vesomni solifenacin/tamsulosin ( EC905) to treat moderate to severe storage symptoms and voiding s...